Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 21 02 2022
accepted: 03 10 2023
medline: 17 11 2023
pubmed: 8 11 2023
entrez: 8 11 2023
Statut: ppublish

Résumé

Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction

Identifiants

pubmed: 37938773
doi: 10.1038/s41586-023-06708-y
pii: 10.1038/s41586-023-06708-y
pmc: PMC10651487
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

616-624

Subventions

Organisme : NIAMS NIH HHS
ID : UH2 AR067685
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067681
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067689
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067694
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR077037
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148435
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NIAMS NIH HHS
ID : UM2 AR067678
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR069655
Pays : United States
Organisme : NIAMS NIH HHS
ID : R21 AR071670
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR081412
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007258
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073290
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007530
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073833
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067688
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR072791
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR063759
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067690
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009379
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067676
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067691
Pays : United States

Investigateurs

Jennifer Albrecht (J)
Jennifer L Barnas (JL)
Joan M Bathon (JM)
David L Boyle (DL)
S Louis Bridges (SL)
Debbie Campbell (D)
Hayley L Carr (HL)
Adam Chicoine (A)
Andrew Cordle (A)
Patrick Dunn (P)
Lindsy Forbess (L)
Peter K Gregersen (PK)
Joel M Guthridge (JM)
Lionel B Ivashkiv (LB)
Kazuyoshi Ishigaki (K)
Judith A James (JA)
Gregory Keras (G)
Ilya Korsunsky (I)
Amit Lakhanpal (A)
James A Lederer (JA)
Zhihan J Li (ZJ)
Yuhong Li (Y)
Andrew McDavid (A)
Mandy J McGeachy (MJ)
Karim Raza (K)
Yakir Reshef (Y)
Christopher Ritchlin (C)
William H Robinson (WH)
Saori Sakaue (S)
Jennifer A Seifert (JA)
Anvita Singaraju (A)
Melanie H Smith (MH)
Dagmar Scheel-Toellner (D)
Paul J Utz (PJ)
Michael H Weisman (MH)
Aaron Wyse (A)
Zhu Zhu (Z)

Informations de copyright

© 2023. The Author(s).

Références

Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis—common origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).
pubmed: 36780677 doi: 10.1056/NEJMra2103726
Alivernini, S., Laria, A., Gremese, E., Zoli, A. & Ferraccioli, G. ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature. Arthritis Res. Ther. 11, R163 (2009).
pubmed: 19886983 pmcid: 3003527 doi: 10.1186/ar2848
Alamanos, Y., Voulgari, P. V. & Drosos, A. A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin. Arthritis Rheum. 36, 182–188 (2006).
pubmed: 17045630 doi: 10.1016/j.semarthrit.2006.08.006
Viatte, S. & Barton, A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin. Immunopathol. 39, 395–408 (2017).
pubmed: 28555384 pmcid: 5486781 doi: 10.1007/s00281-017-0630-4
Oliver, J., Plant, D., Webster, A. P. & Barton, A. Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis. Biomark. Med. 9, 499–512 (2015).
pubmed: 26079957 doi: 10.2217/bmm.15.18
Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470.e5 (2019).
pubmed: 31461658 pmcid: 6718830 doi: 10.1016/j.celrep.2019.07.091
Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021).
pubmed: 33485455 pmcid: 7829614 doi: 10.1016/S0140-6736(20)32341-2
Zhang, F. et al. Defining inflammatory cell states inrheumatoid arthritis joint synovial tissues by integrating single-celltranscriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019).
pubmed: 31061532 pmcid: 6602051 doi: 10.1038/s41590-019-0378-1
Kuo, D. et al. HBEGF
pubmed: 31068444 pmcid: 6726376 doi: 10.1126/scitranslmed.aau8587
Zhang, F. et al. IFN-γ and TNF-α drive a CXCL10
pubmed: 33879239 pmcid: 8057009 doi: 10.1186/s13073-021-00881-3
Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110–114 (2017).
pubmed: 28150777 pmcid: 5349321 doi: 10.1038/nature20810
Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020).
pubmed: 32601335 doi: 10.1038/s41591-020-0939-8
Wang, Y. et al. Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance. Sci Rep. 9, 1–13 (2019).
doi: 10.1038/s41598-019-56279-0
Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259–264 (2020).
pubmed: 32499639 pmcid: 7841716 doi: 10.1038/s41586-020-2222-z
Simmons, D. P. et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol. 7, eabf2846 (2022).
pubmed: 35148199 pmcid: 8991457 doi: 10.1126/sciimmunol.abf2846
Jonsson, A. H. et al. Granzyme K
pubmed: 35704599 pmcid: 9972878 doi: 10.1126/scitranslmed.abo0686
Marks, K. E. & Rao, D. A. T peripheral helper cells in autoimmune diseases. Immunol. Rev. 307, 191–202 (2022).
pubmed: 35103314 pmcid: 9009135 doi: 10.1111/imr.13069
Kochi, Y. Genetics of autoimmune diseases: perspectives from genome-wide association studies. Int. Immunol. 28, 155–161 (2016).
pubmed: 26857735 pmcid: 4889885 doi: 10.1093/intimm/dxw002
Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665–673 (2018).
pubmed: 29925983 pmcid: 7882196 doi: 10.1038/s41590-018-0120-4
Yuseff, M.-I. et al. Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity 35, 361–374 (2011).
pubmed: 21820334 doi: 10.1016/j.immuni.2011.07.008
Rubtsov, A. V. et al. CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs. J. Immunol. 195, 71–79 (2015).
pubmed: 26034175 doi: 10.4049/jimmunol.1500055
Radtke, D. & Bannard, O. Expression of the plasma cell transcriptional regulator Blimp-1 by dark zone germinal center B cells during periods of proliferation. Front. Immunol. 9, 3106 (2018).
pubmed: 30687317 doi: 10.3389/fimmu.2018.03106
Weyand, C. M. & Goronzy, J. J. Ectopic germinal center formation in rheumatoid synovitis. Ann. N. Y. Acad. Sci. 987, 140–149 (2003).
pubmed: 12727633 doi: 10.1111/j.1749-6632.2003.tb06042.x
Ebbo, M., Crinier, A., Vély, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665–678 (2017).
pubmed: 28804130 doi: 10.1038/nri.2017.86
Gordon, S. Phagocytosis: an immunobiologic process. Immunity 44, 463–475 (2016).
pubmed: 26982354 doi: 10.1016/j.immuni.2016.02.026
Jakubzick, C. V., Randolph, G. J. & Henson, P. M. Monocyte differentiation and antigen-presenting functions. Nat. Rev. Immunol. 17, 349–362 (2017).
pubmed: 28436425 doi: 10.1038/nri.2017.28
Lim, H. Y. et al. Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49, 326–341.e7 (2018).
pubmed: 30054204 doi: 10.1016/j.immuni.2018.06.008
Schuch, K. et al. Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties. Obesity 24, 1489–1498 (2016).
pubmed: 27221527 doi: 10.1002/oby.21510
Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641–657.e14 (2020).
pubmed: 32888418 pmcid: 7501731 doi: 10.1016/j.immuni.2020.08.004
Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).
pubmed: 28428369 pmcid: 5775029 doi: 10.1126/science.aah4573
Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e20 (2019).
pubmed: 31675496 doi: 10.1016/j.cell.2019.10.003
Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).
pubmed: 29476097 pmcid: 5824882 doi: 10.1038/s41467-018-02892-y
Korsunsky, I. et al. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med 3, 481–518 (2022).
pubmed: 35649411 doi: 10.1016/j.medj.2022.05.002
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021).
pubmed: 33981032 doi: 10.1038/s41586-021-03549-5
Wigle, J. T. et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505–1513 (2002).
pubmed: 11927535 pmcid: 125938 doi: 10.1093/emboj/21.7.1505
Fujimoto, N. et al. Single-cell mapping reveals new markers and functions of lymphatic endothelial cells in lymph nodes. PLoS Biol. 18, e3000704 (2020).
pubmed: 32251437 pmcid: 7162550 doi: 10.1371/journal.pbio.3000704
Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c
pubmed: 29717110 pmcid: 5931508 doi: 10.1038/s41467-018-03750-7
Schröder, A. E., Greiner, A., Seyfert, C. & Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA. 93, 221–225 (1996).
pubmed: 8552609 pmcid: 40210 doi: 10.1073/pnas.93.1.221
Scheel, T., Gursche, A., Zacher, J., Häupl, T. & Berek, C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum. 63, 63–72 (2011).
pubmed: 20882667 doi: 10.1002/art.27767
Andersen, M. et al. Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study. Ann. Rheum. Dis. 73, 678–683 (2014).
pubmed: 23475981 doi: 10.1136/annrheumdis-2012-202669
Romão, V. C. et al. Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort study. Semin. Arthritis Rheum. 50, 735–743 (2020).
pubmed: 32531503 doi: 10.1016/j.semarthrit.2020.03.018
Just, S. A. et al. Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score. RMD Open 5, e000951 (2019).
pubmed: 31413866 pmcid: 6667976 doi: 10.1136/rmdopen-2019-000951
Kroot, E. J. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831–1835 (2000).
pubmed: 10943873 doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
Rivellese, F. et al. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nat. Med. 28, 1256–1268 (2022).
pubmed: 35589854 pmcid: 9205785 doi: 10.1038/s41591-022-01789-0
Ishigaki, K. et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat. Genet. 54, 1640–1651 (2022).
pubmed: 36333501 pmcid: 10165422 doi: 10.1038/s41588-022-01213-w
Saevarsdottir, S. et al. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann. Rheum. Dis. 81, 1085–1095 (2022).
pubmed: 35470158 doi: 10.1136/annrheumdis-2021-221754
Zhao, H., Li, M., Ouyang, Q., Lin, G. & Hu, L. VEGF promotes endothelial cell differentiation from human embryonic stem cells mainly through PKC-ɛ/η pathway. Stem Cells Dev. 29, 90–99 (2020).
pubmed: 31752619 doi: 10.1089/scd.2019.0172
van Oosterhout, M. et al. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 58, 53–60 (2008).
pubmed: 18163491 doi: 10.1002/art.23148
van Vollenhoven, R. F. & Klareskog, L. Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry. Arthritis Rheum. 48, 1500–1503 (2003).
pubmed: 12794816 doi: 10.1002/art.11027

Auteurs

Fan Zhang (F)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Rheumatology and the Center for Health Artificial Intelligence, University of Colorado School of Medicine, Aurora, CO, USA.

Anna Helena Jonsson (AH)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.

Aparna Nathan (A)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Nghia Millard (N)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Michelle Curtis (M)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Qian Xiao (Q)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Maria Gutierrez-Arcelus (M)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Immunology, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

William Apruzzese (W)

Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, Bethesda, MD, USA.

Gerald F M Watts (GFM)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Dana Weisenfeld (D)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Saba Nayar (S)

Rheumatology Research Group, Institute for Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Birmingham Tissue Analytics, Institute of Translational Medicine, University of Birmingham, Birmingham, UK.

Javier Rangel-Moreno (J)

Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Nida Meednu (N)

Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Kathryne E Marks (KE)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Ian Mantel (I)

Hospital for Special Surgery, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Joyce B Kang (JB)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Laurie Rumker (L)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Joseph Mears (J)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Kamil Slowikowski (K)

Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.

Kathryn Weinand (K)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Dana E Orange (DE)

Hospital for Special Surgery, New York, NY, USA.
Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, NY, USA.

Laura Geraldino-Pardilla (L)

Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Kevin D Deane (KD)

Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.

Darren Tabechian (D)

Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Arnoldas Ceponis (A)

Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA.

Gary S Firestein (GS)

Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA.

Mark Maybury (M)

Rheumatology Research Group, Institute for Inflammation and Ageing, University of Birmingham, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Ilfita Sahbudin (I)

Rheumatology Research Group, Institute for Inflammation and Ageing, University of Birmingham, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Ami Ben-Artzi (A)

Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Arthur M Mandelin (AM)

Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Alessandra Nerviani (A)

Centre for Experimental Medicine and Rheumatology, EULAR Centre of Excellence, William Harvey Research Institute, Queen Mary University of London, London, UK.
Barts Health NHS Trust, Barts Biomedical Research Centre (BRC), National Institute for Health and Care Research (NIHR), London, UK.

Myles J Lewis (MJ)

Centre for Experimental Medicine and Rheumatology, EULAR Centre of Excellence, William Harvey Research Institute, Queen Mary University of London, London, UK.
Barts Health NHS Trust, Barts Biomedical Research Centre (BRC), National Institute for Health and Care Research (NIHR), London, UK.

Felice Rivellese (F)

Centre for Experimental Medicine and Rheumatology, EULAR Centre of Excellence, William Harvey Research Institute, Queen Mary University of London, London, UK.
Barts Health NHS Trust, Barts Biomedical Research Centre (BRC), National Institute for Health and Care Research (NIHR), London, UK.

Costantino Pitzalis (C)

Centre for Experimental Medicine and Rheumatology, EULAR Centre of Excellence, William Harvey Research Institute, Queen Mary University of London, London, UK.
Barts Health NHS Trust, Barts Biomedical Research Centre (BRC), National Institute for Health and Care Research (NIHR), London, UK.
Department of Biomedical Sciences, Humanitas University and Humanitas Research Hospital, Milan, Italy.

Laura B Hughes (LB)

Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Diane Horowitz (D)

Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York, NY, USA.

Edward DiCarlo (E)

Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, USA.

Ellen M Gravallese (EM)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Brendan F Boyce (BF)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Larry W Moreland (LW)

Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Susan M Goodman (SM)

Hospital for Special Surgery, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Harris Perlman (H)

Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

V Michael Holers (VM)

Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.

Katherine P Liao (KP)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Andrew Filer (A)

Rheumatology Research Group, Institute for Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Birmingham Tissue Analytics, Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Vivian P Bykerk (VP)

Hospital for Special Surgery, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Kevin Wei (K)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Deepak A Rao (DA)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Laura T Donlin (LT)

Hospital for Special Surgery, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Jennifer H Anolik (JH)

Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Michael B Brenner (MB)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Soumya Raychaudhuri (S)

Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA. soumya@broadinstitute.org.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. soumya@broadinstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH